Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Cyril Desevaux"'
Autor:
Yunhai Cui, Cyril Desevaux, Ines Truebenbach, Peter Sieger, Klaus Klinder, Alan Long, Achim Sauer
Publikováno v:
Pharmaceutics, Vol 13, Iss 8, p 1146 (2021)
Bidirectional permeability measurement with cellular models grown on Transwell inserts is widely used in pharmaceutical research since it not only provides information about the passive permeability of a drug, but also about transport proteins involv
Externí odkaz:
https://doaj.org/article/450fe8cfeded4f9c92c2b29b6ac8c182
Autor:
Peter Sieger, Cyril Desevaux, Ines Truebenbach, Klaus Klinder, Alan Long, Achim Sauer, Yunhai Cui
Publikováno v:
Pharmaceutics, Vol 13, Iss 1146, p 1146 (2021)
Pharmaceutics
Volume 13
Issue 8
Pharmaceutics
Volume 13
Issue 8
Bidirectional permeability measurement with cellular models grown on Transwell inserts is widely used in pharmaceutical research since it not only provides information about the passive permeability of a drug, but also about transport proteins involv
Autor:
Jérôme M. Giraudel, Martin Fink, Cyril Desevaux, Mark Deurinck, Meindert Danhof, Mathieu Peyrou, Jonathan P. Mochel
Publikováno v:
Chronobiology International. 30:1144-1159
The renin-angiotensin-aldosterone system (RAAS) plays a pivotal role in the regulation of blood pressure and volume homeostasis. Its contribution to the development of cardiovascular diseases has long been recognized. Extensive literature has shown t
Autor:
Pascal Dubreuil, Cyril Desevaux
Publikováno v:
Combinatorial Chemistry & High Throughput Screening. 9:171-174
Growth hormone-releasing factor was discovered in 1982 by Guillemin and has been subjected to intense investigations because of its huge potential applications. The major concerns encountered with the native molecules were their short half-lives in v
Publikováno v:
Journal of Orthopaedic Research. 22:1351-1357
Crosslinked high amylose starch (CLHAS) matrix was used as a biodegradable drug delivery implant for the prevention and treatment of osteomyelitis. Thirty-two dogs underwent the femoral insertion of a screw inoculated with Staphylococcus aureus and w
Publikováno v:
Journal of Controlled Release. 82:83-93
The objective of this study was to characterize in vitro the potential of crosslinked high amylose starch (CLHAS) as an implant matrix for the delivery of ciprofloxacin (CFX). Direct compression of dry blends of four different matrices: control CLHAS
Publikováno v:
Journal of Controlled Release. 82:95-103
Publikováno v:
International Journal of Pharmaceutics. 232:119-129
Cross-linked high amylose starch (Contramid®) was investigated as a solid implant for evaluation of host response in mice and as a possible delivery system for a human growth hormone-releasing factor analog (Hex-hGRF) release profile in pigs. Sevent
Publikováno v:
Journal of Biomedical Materials Research. 63:772-779
The biocompatibility and degradation characteristics of cross-linked high amylose starch (Contramid®) were investigated in rats over 4 months. Contramid® pellets (3-mm diameter and thickness) obtained by direct compression, were implanted subcutane
Autor:
Cyril Desevaux, Martin Fink, Charlotte Bon, Mathieu Peyrou, Meindert Danhof, Jonathan P. Mochel, Jérôme M. Giraudel, Bruno Bieth, Mark Deurinck
Publikováno v:
Chronobiology international. 31(5)
The contribution of the renin-angiotensin-aldosterone system (RAAS) to the development of congestive heart failure (CHF) and hypertension (HT) has long been recognized. Medications that are commonly used in the course of CHF and HT are most often giv